NCT05778994

Brief Summary

The goal of this clinical trial is to assess the possible efficacy of the INTORUS device as an element to reduce test anxiety in university students. The main question\[s\] it aims to answer are: Can the INTORUS device be used as a tool to reduce anxiety? Once informed, those participants who meet the inclusion/exclusion criteria and sign the informed consent to participate in the study will be randomly divided into two groups. The randomization procedure will be carried out using the OxMaR (Oxford Minimization and Randomization) software. All participants will be given the Sociodemographic Questionnaire, Self-efficacy Scale and anxiety questionnaire prior to the start of the study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 30, 2023

Completed
2 days until next milestone

Study Start

First participant enrolled

February 1, 2023

Completed
28 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2023

Completed
21 days until next milestone

First Posted

Study publicly available on registry

March 22, 2023

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2023

Completed
Last Updated

December 1, 2023

Status Verified

November 1, 2023

Enrollment Period

28 days

First QC Date

January 30, 2023

Last Update Submit

November 30, 2023

Conditions

Keywords

STUDENTSANXIETYOCCUPATIONAL THERAPY

Outcome Measures

Primary Outcomes (1)

  • Changes in the BECK anxiety questionnaire over 3 months

    Questionnaire to measure anxiety. The questionnaire consists of 21 questions, providing a range of scores between 0 and 63. The suggested cut-off points for interpreting the result obtained are as follows: 00-21 - Very low anxiety 22-35 - Moderate anxiety over 36 - Severe anxiety

    Measures before starting the intervention. through study completion, an average of 3 months.

Secondary Outcomes (2)

  • Changes in the Perceived self-efficacy scale in academic situations

    Measures before starting the intervention. through study completion, an average of 3 months.

  • Changes in the questionnaire for the assessment of anxiety before exams

    Measures before starting the intervention. through study completion, an average of 3 months.

Other Outcomes (1)

  • Participant satisfaction questionnaire

    Through study completion, an average of 3 months

Study Arms (2)

EXPERIMENTAL

EXPERIMENTAL

Group that performs therapy with intorus

Device: INTORUS

CONTROL

NO INTERVENTION

Group without intervention

Interventions

INTORUSDEVICE

Exercise protocol with intorus

EXPERIMENTAL

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Students of the Degree in Occupational Therapy at the University of Extremadura.
  • Students who are going to study the Degree in Occupational Therapy in person.

You may not qualify if:

  • Not wanting to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Blanca Gonzalez Sanchez

Cáceres, 10001, Spain

Location

MeSH Terms

Conditions

Anxiety Disorders

Condition Hierarchy (Ancestors)

Mental Disorders

Study Officials

  • Blanca González Sáchez, Doctor

    Universidad de Extremadura

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
DOCTOR. PRINCIPAL INVESTIGATOR

Study Record Dates

First Submitted

January 30, 2023

First Posted

March 22, 2023

Study Start

February 1, 2023

Primary Completion

March 1, 2023

Study Completion

July 31, 2023

Last Updated

December 1, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

Locations